Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; and Pyrogel HPS for applications within the power generation market. It also offers Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.

Aspen Aerogels, Inc.

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Aspen Aerogels Inc (Symbol: ASPN), where a total of 15,908 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 90.3% of ASPN's average daily trading volume over the past month of 1.8 million shares. Particularly high volume was seen for the $10 strike call option expiring September 19, 2025, with 3,751 contracts trading so far today, representing approximately 375,100 underlying shares of ASPN. Below is a chart showing ASPN's trailing twelve month trading history, with the $10 strike highlighted in orange:
Grindr Inc (Symbol: GRND) options are showing a volume of 14,627 contracts thus far today. That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 86.2% of GRND's average daily trading volume over the past month, of 1.7 million shares. Especially high volume was seen for the $18 strike put option expiring August 15, 2025, with 11,121 contracts trading so far today, representing approximately 1.1 million underlying shares of GRND. Below is a chart showing GRND's trailing twelve month trading history, with the $18 strike highlighted in orange:
And Roblox Corp (Symbol: RBLX) options are showing a volume of 67,978 contracts thus far today. That number of contracts represents approximately 6.8 million underlying shares, working out to a sizeable 84.4% of RBLX's average daily trading volume over the past month, of 8.1 million shares. Especially high volume was seen for the $100 strike put option expiring August 15, 2025, with 10,542 contracts trading so far today, representing approximately 1.1 million underlying shares of RBLX. Below is a chart showing RBLX's trailing twelve month trading history, with the $100 strike highlighted in orange:
For the various different available expirations for ASPN options, GRND options, or RBLX options, visit StockOptionsChannel.com.
EEFT shares outstanding history
WSO.B Average Annual Return
Funds Holding CLOA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Noteworthy Wednesday Option Activity: ASPN, GRND, RBLX

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Fidelity MSCI Materials Index ETF (Symbol: FMAT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $55.86 per unit.
With FMAT trading at a recent price near $47.79 per unit, that means that analysts see 16.88% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of FMAT's underlying holdings with notable upside to their analyst target prices are Aspen Aerogels Inc (Symbol: ASPN), PureCycle Technologies Inc (Symbol: PCT), and TriMas Corp (Symbol: TRS). Although ASPN has traded at a recent price of $4.31/share, the average analyst target is 325.36% higher at $18.33/share. Similarly, PCT has 72.19% upside from the recent share price of $7.55 if the average analyst target price of $13.00/share is reached, and analysts on average are expecting TRS to reach a target price of $40.00/share, which is 63.13% above the recent price of $24.52. Below is a twelve month price history chart comparing the stock performance of ASPN, PCT, and TRS:
Below is a summary table of the current analyst target prices discussed above:
Name
Symbol
Recent Price
Avg. Analyst 12-Mo. Target
% Upside to Target
Fidelity MSCI Materials Index ETF
FMAT
$47.79
$55.86
16.88%
Aspen Aerogels Inc
ASPN
$4.31
$18.33
325.36%
PureCycle Technologies Inc
PCT
$7.55
$13.00
72.19%
TriMas Corp
TRS
$24.52
$40.00
63.13%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
Also see:
Top Ten Hedge Funds Holding TOI
Funds Holding MER
Eaton RSI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

FMAT's Underlying Holdings Could Mean 17% Gain Potential

Validea Joseph Piotroski Strategy Daily Upgrade Report - 4/22/2025

In this video, I will talk about five interesting companies worth your attention. I chose companies in different industries that could provide significant upside for long-term investors. Watch the short video to learn more, consider subscribing, and click the special offer link below.
*Stock prices used were from the trading day of Jan. 14, 2025. The video was published on Jan. 15, 2025.
Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
Don’t miss this second chance at a potentially lucrative opportunity
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
Nvidia: if you invested $1,000 when we doubled down in 2009, you’d have $346,349!*
Apple: if you invested $1,000 when we doubled down in 2008, you’d have $43,229!*
Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $454,283!*
Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.
See 3 “Double Down” stocks »
*Stock Advisor returns as of January 13, 2025
Neil Rozenbaum has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends First Solar and Lam Research. The Motley Fool recommends Grab and Novo Nordisk. The Motley Fool has a disclosure policy. Neil is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

5 Stocks to Buy Now for Big Returns in 2025

The second year of Wall Street's bull market rally didn't disappoint. When the closing bell tolled on Dec. 31, the ageless Dow Jones Industrial Average, benchmark S&P 500, and growth stock-focused Nasdaq Composite had respectively gained 13%, 23%, and 29%, with all three indexes rallying to record-closing highs multiple times in 2024.
However, putting your money to work on Wall Street is all about looking to the future and not reflecting too much on the past. Regardless of whether the bull market extends for a third year or the mighty bear returns in 2025, standout stocks can still be found.
Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
For investors who prefer to swing for the fences and can stomach a bit of risk and volatility, the following seven magnificent stocks have all the tools and intangibles needed to double your money in 2025.
1. Nio
The first sensational growth stock that's contending with challenges but has the catalysts to overcome them and deliver a triple-digit return in the new year is China-based electric-vehicle (EV) manufacturer Nio (NYSE: NIO).
Although China's economy has stumbled a bit in the two years since lifting its restrictive COVID-19 mitigation measures, Nio has undeniably benefited from supply chain kinks being resolved. Through the first 11 months of 2024, Nio produced nearly 191,000 EVs, which represents a 34% increase from the same period in 2023. In the latter-half of the year, production has consistently come in around 20,000 units per month. More output leads to more revenue and brand recognition, and should help to reduce losses in the coming years.
Perhaps the biggest catalysts for Nio in the new year are the international debut and ramp-up of its Onvo brand, as well as the domestic debut of Firefly. Whereas Nio has primarily focused on middle-to-high-earning EV buyers, the Onvo and Firefly brands are targeted at more cost-conscious consumers. Onvo EVs have a mid-tier price point, with deliveries expected to begin in Europe in early 2025. Meanwhile Firefly is a compact EV that was debuted last month. On a combined basis, Onvo and Firefly could potentially double Nio's monthly EV production.
Don't overlook Nio's out-of-the-box innovation, either. The company has north of 2,800 battery swap stations in its home market of China, along with 4,175 charging stations. The ability to swap or upgrade batteries in five minutes or less is a potential infrastructure game-changer for EV buyers, and it should help Nio generate high-margin service revenue and keep existing owners loyal to the brand.
2. PubMatic
A second sensational stock that can double your money in 2025 if all goes well with the U.S. economy is adtech up-and-comer PubMatic (NASDAQ: PUBM). Ad spending is highly cyclical, which means worries about an economic slowdown can sometimes be enough to weaken sales and profits for advertising-based businesses.
The good news for PubMatic is that ad-driven companies have history in their corner. The U.S. economy spends a disproportionate amount of time expanding relative to contracting, which leads to steady growth in ad spending over time.
What makes PubMatic so special is that its entire focus is on digital advertising, which is growing considerably faster than traditional forms of marketing (e.g., billboard, print, and legacy TV). The company's cloud-based programmatic ad platform helps publishing companies sell their digital display space, with a focus on video, mobile, and connected TV advertisements. Cumulative ad spend in all three categories can grow by a double-digit percentage in 2025.
Another selling point for PubMatic was the choice by management to build out its cloud-based platform. While relying on a third party would have been considerably easier, taking the path it did will allow it to hang onto more its revenue as it scales.
The icing on the cake is that PubMatic's cash accounts for 20% of its market cap, and its forward price-to-earnings (P/E) ratio of 17 is cheap next to forecasts of sustained double-digit growth in earnings per share (EPS).
3. Cloudflare
Another high-octane growth stock that's the epitome of swinging for the fences is artificial intelligence (AI)-driven cloud services provider Cloudflare (NYSE: NET). At nearly 18 times forecast sales for 2025, Cloudflare is exceptionally pricey. But if AI euphoria continues to play out, Cloudflare could see its sales blow past expectations this year.
The first thing to note about Cloudflare is that some of the services it provides have evolved into a basic necessity. Specifically, the company's Cloudflare One platform blocks cyber threats and guards access to critical information. As businesses continue their shift into the cloud, their reliance on third-party providers like Cloudflare grows.
Secondly, Cloudflare has done a phenomenal job of attracting larger clientele. Nearly two-thirds of sales can be traced to large customers, which are defined as clients that generate greater than $100,000 in annual recurring revenue for the company. Between Sept. 30, 2022 and Sept. 30, 2024, the number of large customers jumped by 71% to 3,265. These colossal businesses have helped to lift Cloudflare's adjusted gross margin to 79%.
However, the wildcard for Cloudflare in 2025 will be its role in supporting AI in edge computing. Cloudflare's Workers AI platform allows businesses to run machine learning models within the Cloudflare network. Cloudflare has the potential to play a critical in role in large language model development for many of America's most-influential businesses -- and it could result in full-year sales growth far exceeding the current consensus of 26% in 2025.
4. Aspen Aerogels
A fourth magnificent hypergrowth stock that's fully capable of a triple-digit return in the new year is electrification and energy sustainability solutions provider Aspen Aerogels (NYSE: ASPN).
Admittedly, clean energy and sustainability aren't forefront investments with President-elect Donald Trump set to take office in less than three weeks. Nevertheless, the EV revolution, despite its potholes, is a path to sustainable double-digit sales growth and profits for Aspen.
Aspen Aerogels' claim to fame is its PyroThin products, which utilize carbon aerogel to improve the performance of lithium-ion batteries used in EVs. Aspen's technology should allow automakers to produce EVs with improved range, which is sort of a necessity given that EV charging infrastructure is still lacking in the U.S.
Aspen's Thermal Barrier segment generated $90.6 million of the $117.3 million in total sales reported for the September-ended quarter. More importantly, $90.6 million is 176% more than what this division generated in the third quarter of 2023. Between February 2024 and November 2024, the company's full-year revenue outlook (for all segments) has grown from "greater than $350 million" to $450 million.
Best of all, Aspen Aerogels looks to be shifting to recurring profits well ahead of schedule. Mindful cost-cutting coupled with improved margins can turn this floundering stock around in a big way in 2025.
5. SSR Mining
Yes, there is a market for stocks beyond the technology sector! A fifth intriguing stock that has the potential to double your money in 2025 is precious-metal miner SSR Mining (NASDAQ: SSRM). Though its shares tend to ebb-and-flow with the spot price of silver, SSR generates most of its revenue from gold production.
Whereas precious metals soared in 2024, SSR Mining stock swooned. In mid-February, shares plunged by more than 50% after a heap leach pad collapsed at the Copler gold mine in Turkey and tragically killed nine workers. The company has since pegged remediation costs at $250 million to $300 million, with a timeline ranging from 24 to 36 months. While this is terrible news, there appears to be a light at the end of the tunnel for SSR Mining and its shareholders.
To start with, SSR is unique in the sense that its management team avoided going deeply into debt. While most gold miners are (pardon the pun) still digging themselves out of debt-driven holes, SSR has maintained a net-cash position. In other words, it has the capital to cover remediation work at Copler, as well as advance projects at other mines.
There's also the possibility of having its environmental permit, which was cancelled days after the heap leach pad collapse, reinstated. What's noteworthy is that Turkey didn't cancel the mining licenses, which expire in 2026. This suggests SSR simply needs to provide a concrete plan to Turkey's Energy Ministry to deal with future mining waste to regain its environmental permit. Though there's no specific timeline for this to happen, it seems likely to occur within the next 24 months.
Lastly, SSR Mining announced it was buying the Cripple Creek & Victor gold mine from Newmont last month. Cripple Creek & Victor can provide 150,000-plus ounces of annual gold production and be immediately accretive to cash flow and EPS. It should help replace close to half of the annual production temporarily lost at Copler.
6. Trulieve Cannabis
Although marijuana stocks have been a buzzkill since shortly after President Joe Biden took office in January 2021, the new year could be particularly green for U.S. multi-state operator (MSO) Trulieve Cannabis (OTC: TCNNF).
Let's be blunt (pun fully intended): things didn't go as Trulieve hoped during the 2024 election cycle. President-elect Trump and his appointees are far less likely than Democratic Party presidential nominee Kamala Harris would have been to eventually legal cannabis at the federal level. To boot, Floridians voted against an amendment that would have legalized recreational marijuana in the Sunshine State. Most of Trulieve's dispensaries are located in Florida.
But there's a silver lining. Last year, the U.S. Drug Enforcement Administration proposed rescheduling cannabis under the Controlled Substances Act from Schedule I to Schedule III. Assuming the process plays out through hearings and this rescheduling occurs this year, as expected, it's going to be a massive help to the bottom lines of U.S. MSOs.
U.S. Tax Code 280E doesn't allow companies that sell a Schedule I or II substance to take normal business deductions, save for cost of goods sold. However, companies selling Schedule III substances can take normal business deductions on their taxes. The ability to take these deductions should vastly improve Trulieve's operating results.
Being the kingpin of Florida's higher-margin medical marijuana market should prove quite profitable.
7. Applied Digital
The final magnificent stock that represents a true swing for the fences and is capable of doubling your money in 2025 is digital infrastructure solutions company Applied Digital (NASDAQ: APLD).
The biggest risk and reward for Applied Digital is the excitement surrounding AI. Since the mid-1990s, every next-big-thing innovation, technology, or trend has navigated an early stage bubble-bursting event. Based on what history tells us, it's unlikely that artificial intelligence is the exception to the rule. If the AI bubble were to burst, unproven businesses like Applied Digital would likely take it on the chin.
However, if unwavering optimism for AI continues throughout 2025, infrastructure providers should be logical winners. Applied Digital CEO Wes Cummins noted in October that his company was in the process of finalizing a lease agreement with a U.S. hyperscaler for a 100 megawatt, 369,000-square-foot facility designed for high-performance computing (HPC) applications, including AI. Acting as a data-center host, as well as providing HPC applications for businesses, is expected to lead to revenue growth of greater than 50% in 2024, as well as in 2025.
What's arguably even more exciting is that Nvidia purchased 7,716,050 shares of Applied Digital stock during the September-ended quarter. This $63.7 million position (as of the end of the third quarter) made it Nvidia's second-largest investment behind only Arm Holdings.
Nvidia would love to see Applied Digital succeed. Build-to-suit HPC data centers fuels more demand for Nvidia's market-leading graphics processing units (GPUs). Plus, Applied Digital's own AI cloud operations are powered by Nvidia's GPUs. This investment is about as close to a ringing endorsement as an under-the-radar company can get from Wall Street's AI darling.
Should you invest $1,000 in Nio right now?
Before you buy stock in Nio, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nio wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $823,000!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of December 30, 2024
Sean Williams has positions in PubMatic and SSR Mining. The Motley Fool has positions in and recommends Cloudflare, Nvidia, and PubMatic. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

7 Magnificent Stocks That Can Double Your Money in 2025

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.
In trading on Tuesday, shares of Aspen Aerogels Inc (Symbol: ASPN) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $13.95 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 65.5. A bullish investor could look at ASPN's 29.9 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ASPN shares:
Looking at the chart above, ASPN's low point in its 52 week range is $10.36 per share, with $33.15 as the 52 week high point — that compares with a last trade of $13.82.
Find out what 9 other oversold stocks you need to know about »
Also see:
ETFs Holding LUK
Funds Holding BE
General Dynamics shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Aspen Aerogels Enters Oversold Territory (ASPN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.
In trading on Wednesday, shares of Aspen Aerogels Inc (Symbol: ASPN) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $16.26 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 61.9. A bullish investor could look at ASPN's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ASPN shares:
Looking at the chart above, ASPN's low point in its 52 week range is $8.76 per share, with $33.15 as the 52 week high point — that compares with a last trade of $17.01.
Find out what 9 other oversold stocks you need to know about »
Also see:
Monthly Dividend Paying REITs
PGRE Dividend Growth Rate
PRVL market cap history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aspen Aerogels Inc (Symbol: ASPN), where a total volume of 15,079 contracts has been traded thus far today, a contract volume which is representative of approximately 1.5 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 57.5% of ASPN's average daily trading volume over the past month, of 2.6 million shares. Especially high volume was seen for the $22.50 strike put option expiring November 15, 2024, with 4,071 contracts trading so far today, representing approximately 407,100 underlying shares of ASPN. Below is a chart showing ASPN's trailing twelve month trading history, with the $22.50 strike highlighted in orange:
Target Corp (Symbol: TGT) options are showing a volume of 18,090 contracts thus far today. That number of contracts represents approximately 1.8 million underlying shares, working out to a sizeable 55.6% of TGT's average daily trading volume over the past month, of 3.3 million shares. Particularly high volume was seen for the $150 strike put option expiring October 25, 2024, with 1,524 contracts trading so far today, representing approximately 152,400 underlying shares of TGT. Below is a chart showing TGT's trailing twelve month trading history, with the $150 strike highlighted in orange:
And LendingClub Corp (Symbol: LC) options are showing a volume of 7,448 contracts thus far today. That number of contracts represents approximately 744,800 underlying shares, working out to a sizeable 55.6% of LC's average daily trading volume over the past month, of 1.3 million shares. Particularly high volume was seen for the $15 strike call option expiring November 15, 2024, with 5,747 contracts trading so far today, representing approximately 574,700 underlying shares of LC. Below is a chart showing LC's trailing twelve month trading history, with the $15 strike highlighted in orange:
For the various different available expirations for ASPN options, TGT options, or LC options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Top Stocks Held By Jim Simons
JEF market cap history
Funds Holding UFS
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Notable Tuesday Option Activity: ASPN, TGT, LC

(RTTNews) - Aspen Aerogels Inc. (ASPN) said it priced its underwritten public offering of 4.25 million shares of its common stock at $20.00 per share.
In addition, the Company has granted the underwriters of the offering a 30-day option to purchase up to an additional 637,500 shares of common stock at the public offering price, less underwriting discounts and commissions.
The company expects the gross proceeds from the offering to be approximately $85 million, before deducting underwriting discounts and commissions and estimated offering expenses, and excluding any exercise of the underwriters' option to purchase additional shares of common stock.
The offering is expected to close on October 23, 2024.
Aspen plans to use the net proceeds from the offering for working capital, capital expenditures and general corporate purposes.
Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the offering.
ASPN closed Monday's regular trading at $21.33 down $0.27 or 1.25%. In the after-hours trading, the stock further dropped $0.88 or 4.13%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Aspen Aerogels Prices Public Offering Of 4.25 Mln Shares At $20.00/shr

Investing in individual growth stocks can be a rollercoaster ride, but the potential rewards can be substantial. Since the 2008 financial crisis, numerous growth stocks have significantly outperformed passive index funds.
Some standout performers have even delivered returns exceeding 1,000% in less than five years. Nvidia (NASDAQ: NVDA), the chipmaker at the heart of the artificial intelligence (AI) revolution, exemplifies this potential, turning a $10,000 investment into nearly $300,000 over the past 60 months.
NVDA Total Return Level data by YCharts.
My tax-advantaged portfolios include 14 stocks primarily held for their growth prospects. While some of these growth stocks pay dividends, that's not the main reason for owning them.
Here, I'll explain why I continue to invest in each of these companies and discuss their 12-month upside potential based on Wall Street's consensus price targets and year-to-date performance.
Archer Aviation: Pioneering electric air taxis
Archer Aviation (NYSE: ACHR) is at the forefront of the electric vertical takeoff and landing (eVTOL) aircraft industry. The company aims to revolutionize urban transportation with its electric air taxis, potentially disrupting the $1 trillion global urban air mobility market.
Wall Street's consensus suggests a 209% upside potential for Archer Aviation, highlighting its promising long-term growth prospects despite a negative 49.8% year-to-date performance. The company's progress in aircraft development and strategic partnerships with major airlines bolster its potential for future success.
Aspen Aerogels: Innovating in high-performance insulation
Aspen Aerogels (NYSE: ASPN) develops advanced aerogel insulation materials for various industries, including electric vehicles, energy infrastructure, and sustainable building materials. The company's products offer superior thermal performance and energy efficiency.
Aspen Aerogels has outperformed the S&P 500 with a 44.2% year-to-date gain in 2024. The 43.8% upside potential projected by analysts over the next 12 months stems from the growing demand for high-performance insulation materials across multiple industries.
CRISPR Therapeutics: Pioneering gene-editing therapies
CRISPR Therapeutics (NASDAQ: CRSP) is at the forefront of developing gene-editing therapies for serious diseases. Fewer than 12 months ago, the company achieved a major milestone with the approval of Casgevy, its groundbreaking treatment for sickle cell disease and beta-thalassemia, developed in partnership with Vertex Pharmaceuticals.
Wall Street projections indicate a 72% upside for CRISPR Therapeutics over the next 12 months despite a negative 23.6% year-to-date performance. Along with the company's robust pipeline, the recent approval of Casgevy, the first CRISPR-based therapy to reach the market, could drive significant long-term growth.
CRSP data by YCharts.
GE Aerospace: Focused on aviation innovation
Following its recent transformation, General Electric has become GE Aerospace (NYSE: GE), concentrating on its core aviation business. The company is a global leader in aircraft engines and systems, positioning it to benefit from the recovery and growth in the commercial aviation sector.
GE Aerospace has outperformed the S&P 500 with an 88.8% year-to-date gain. The 6.3% upside potential projected by analysts points to the company's streamlined focus on aviation and improving industry dynamics.
Howmet Aerospace: Advancing aerospace innovation
Howmet Aerospace (NYSE: HWM) provides advanced engineered solutions for the aerospace and transportation industries. The company's lightweight materials and innovative technologies are crucial for improving fuel efficiency and performance in aircraft and vehicles.
Howmet Aerospace has significantly outperformed the S&P 500 with an 89.6% year-to-date gain. The modest 2.6% upside projected by analysts highlights the company's strong recent performance and solid position in the recovering aerospace market.
HWM data by YCharts.
Intuitive Machines: Pioneering commercial lunar missions
Intuitive Machines (NASDAQ: LUNR) is a leader in commercial lunar payload delivery and orbital services. The company aims to become a key player in the growing commercial space industry with planned lunar missions and innovative space technologies.
Intuitive Machines has significantly outperformed the S&P 500 with a 206% year-to-date gain. Analysts' 38.2% upside potential projected over the next 12 months underscores the company's potential in the rapidly expanding commercial space market.
LUNR data by YCharts.
Joby Aviation: Transforming urban air mobility
Joby Aviation (NYSE: JOBY) is developing eVTOL aircraft for commercial passenger service. The company aims to launch an air taxi service that could revolutionize urban transportation. It also recently scored a major investment from Toyota Motor.
Wall Street projections indicate a 45.7% upside potential for Joby Aviation over the next 12 months despite a negative 17.2% year-to-date performance. The company's progress in aircraft development and certification processes could position it as a leader in the emerging urban air mobility market.
Kratos Defense & Security Solutions: Innovating in defense technology
Kratos Defense & Security Solutions (NASDAQ: KTOS) specializes in uncrewed systems, satellite communications, and cybersecurity for defense and commercial markets. The company's focus on next-generation defense technologies positions it well in the evolving defense landscape.
Kratos has gained 24.9% year to date, modestly outperforming the broader market represented by the S&P 500. The company's innovative defense solutions and growing government contracts could drive significant future growth. That said, Wall Street analysts think the stock is fairly valued at current levels.
KTOS data by YCharts.
Navitas Semiconductor: Enabling efficient power electronics
Navitas Semiconductor (NASDAQ: NVTS) develops gallium nitride (GaN) power integrated circuits, which offer superior efficiency and performance compared to traditional silicon-based solutions. The company's technology has applications in fast charging, renewable energy, and electric vehicles.
Despite a negative 67.7% year-to-date performance, Wall Street projections suggest a 114% upside potential for Navitas Semiconductor. The growing adoption of GaN technology in various industries could drive significant long-term growth for the company.
NVTS data by YCharts.
Nvidia: Powering the AI revolution
Nvidia is a leader in graphics processing units (GPUs) and is at the forefront of the AI computing revolution. The company's chips are essential for training and running advanced AI models, positioning it to benefit from the rapidly growing AI market.
Nvidia's stock has soared 178% year to date, significantly outperforming the S&P 500. The chipmaker's strong market position and growth prospects in AI and other high-performance computing applications contribute to the 10.4% gain projected by analysts over the next 12 months.
NVDA data by YCharts.
Palantir Technologies: Harnessing data for actionable insights
Palantir Technologies (NYSE: PLTR) provides data analytics software to government agencies and commercial clients, helping them make better decisions. The company's AI-powered platforms are increasingly crucial for organizations dealing with complex data challenges.
Palantir Technologies has surged 150% year to date, outperforming the S&P 500 by a wide margin. While current projections suggest a -34% potential downside from current levels, the company's expanding commercial business and AI capabilities could drive long-term growth.
PLTR data by YCharts.
Prime Medicine: Advancing precision gene editing
Prime Medicine (NASDAQ: PRME) is developing a next-generation gene-editing platform called prime editing, which offers potential advantages over existing CRISPR technologies. The company aims to develop therapies for a wide range of genetic diseases.
Prime Medicine's stock has fallen 57.7% year to date, but Wall Street projections suggest a 269% upside potential from current levels. The company's innovative gene-editing technology and broad therapeutic potential could drive substantial long-term growth.
PRME data by YCharts.
Rocket Lab USA: Expanding access to space
Rocket Lab USA (NASDAQ: RKLB) provides launch services and spacecraft solutions for the growing small satellite market. The company aims to increase the frequency and reliability of space access with its innovative rocket technology and manufacturing capabilities.
Rocket Lab USA has outperformed the S&P 500 with a 76.6% year-to-date gain. While current projections suggest a -20% potential downside, the company's expanding launch capabilities and space systems business could drive long-term growth in the commercial space industry.
RKLB data by YCharts.
Taiwan Semiconductor Manufacturing: Dominating chip production
Taiwan Semiconductor Manufacturing (NYSE: TSM) is the world's largest contract chipmaker, supplying advanced semiconductors to tech giants globally. The company's technological leadership and scale give it a significant competitive advantage in the growing semiconductor market.
Taiwan Semiconductor Manufacturing has outperformed the S&P 500 with an 84.8% year-to-date gain. The modest 3.7% upside projected by analysts underscores the company's strong recent performance and crucial role in the global technology supply chain.
Should you invest $1,000 in Nvidia right now?
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $806,459!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
See the 10 stocks »
*Stock Advisor returns as of October 14, 2024
George Budwell has positions in Archer Aviation, Aspen Aerogels, CRISPR Therapeutics, GE Aerospace, Howmet Aerospace, Intuitive Machines, Joby Aviation, Kratos Defense & Security Solutions, Navitas Semiconductor, Nvidia, Palantir Technologies, Prime Medicine, Rocket Lab USA, Taiwan Semiconductor Manufacturing, and Toyota Motor. The Motley Fool has positions in and recommends CRISPR Therapeutics, Nvidia, Palantir Technologies, Taiwan Semiconductor Manufacturing, and Vertex Pharmaceuticals. The Motley Fool recommends Rocket Lab USA. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

Indicator	TTM Median
P/E	33.47 21.05
Price/Sales	0.98 1.20
P/B	0.76 1.57
P/FCF	0.00 20.51

Indicator	TTM Median
ROE	2.44 10.93
ROA	1.66 5.60
ROI	1.97 7.38
Net Worth	0.46 1.42
Quick Ratio	3.29 1.18
Current Ratio	3.72 1.99

Indicator	TTM Median
Net Profit Margin	2.87 7.56
Operating Margin	11.92 12.32
Gross Margin	40.40 27.83
Return on tangible equity	2.44 14.37

Indicator	TTM Median
EPS	0.06 0.27
EPS Forecast	0.07 0.24
Revenue	123.00M 204.00M
Gross Profit	47.00M —
EBITDA	21.00M —

Aspen Aerogels, Inc.

Fundamental ASPN

Valuation

Debts

Efficiency

Other ratios

Revenue